UAE Approves Lipfendra for Cholesterol
The Emirates Foundation for Medicine has announced the approval of the drug "Liphendra," used to treat high levels of bad cholesterol (LDL-C) in adults, including some hereditary cases. The UAE is the second country in the world to adopt this treatment, which is taken once daily and works to lower bad cholesterol alongside a healthy lifestyle. The use of this medication enhances the quality of healthcare and aligns with the country's efforts to accelerate the delivery of innovative medicines to patients. It also encourages the community to adopt a healthy lifestyle and consult with physicians to reduce the risks of cardiovascular diseases.
articleDetails.fontSize.sizeحجم النص
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading